5.1.1.4	drug development	enzyme has potential to be used as a drug target for this parasite-based trypanosomiasis	705596	
5.1.1.4	medicine	potential of the enzyme as a critical target for drug development against Chagas‘ disease. The enzyme is absent in mammalian host, suggesting that inhibition of proline racemase may have therapeutic potential	652377	
5.1.1.4	medicine	potential of the enzyme as a critical target for drug development against Chaga‘s disease. The enzyme is absent in mammalian host, suggesting that inhibition of proline racemase may have therapeutic potential	652377	
5.1.1.4	medicine	proline racemase based PCR can be used, preferably in combination with ITS-1 PCR, as a speciesspecific diagnostic test for Trypanosoma vivax infections worldwide	-, 749144